Strategy

Jun 01, 2013
Pharmaceutical Executive
New stakeholders, innovative technologies, and emergent synergies in government are combining to build fresh momentum behind the old issue of medication adherence. The question is will Big Pharma be flexible enough to keep pace with the changes?
Jun 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Despite their high status, management gurus aren't always on point when it comes to pharma, writes John Ansell.
May 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
In the world of patient education, processes, policies, and oversight differ vastly. There is no overarching governance structure. There isn't an accreditation process for educational interventions or patient advocacy organizations that develop the education.
May 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
New approaches to managing reimbursements for pharmacy benefit programs are testing Big Pharma.
May 01, 2013
Pharmaceutical Executive
What is industry icon Fred Hassan's management formula for staying fresh in an era of market churn?
May 01, 2013
Pharmaceutical Executive
New research from the Tufts Center for the Study of Drug Development identifies a significant contributor to the rising cost of clinical trials—the first step in meeting a growing strategic imperative to help senior management and the regulatory community craft new approaches to make trials more efficient in delivering results to clinicians and patients.
Mar 01, 2013
Pharmaceutical Executive
Timely engagement is the key to expanding the use of companion diagnostics.
Mar 01, 2013
Pharmaceutical Executive
A proactive approach to talent and organization planning is the hidden trump card in prevailing with payers.
Mar 01, 2013
Pharmaceutical Executive
Ken Getz of the Tufts University Center for the Study of Drug Development (CSDD) explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.
Mar 01, 2013
Pharmaceutical Executive
Companies that adopt this new methodology will have a longstanding competitive advantage over those companies conducting business as usual.
native1_300x100
lorem ipsum